Pfizer to Deliver 13 Million COVID-19 Vaccine Doses per Week by Mid-March

By Joshua Summers Feb 22 2021, 23:48 PM EST

Amid the rollout and inoculation of the COVID-19 vaccines in the United States, Pfizer Inc. expects to hand out 13 million doses of its vaccine every week by the middle of March. Reuters noted that a Pfizer executive said in a congressional hearing through a prepared testimony that the company will double its shipments from early February.

Bloomberg reported that many Americans have already been inoculated with at least one dose of the COVID-19 vaccine. Around 64.2 million doses have already been administered, with an average of 1.37 million doses per day in the past week.

Pfizer COVID-19 Vaccine

Pfizer's chief business officer, John Young, said Pfizer has already transported 40 million doses to various locations across the United States, U.S. News reported.

Young further noted that the company is right on track in delivering 120 million shots of their two-dose procedure by the end of March.

According to The Straits Times, the pharmaceutical giant is prepared to provide a total of 300 million shots to the U.S. by the end of July, and it has increased its global production expectations for 2021 to at least two billion doses.

Vice President of Medical Affairs for Johnson & Johnson's, Richard Nettles, said the company would be able to transport at least 20 million doses of its single-dose shot by the end of March after gaining U.S. regulatory authorization. The firm targets to ship 100 million doses by the middle of 2021.

On the other hand, Moderna President Stephen Hoge noted that their company plans to deliver 100 million doses of their two-dose shot by the end of March and 300 million by the end of July.

COVID -19 Cases Are Dropping

Citing a CBS News interview, Deseret News reported that former head of the Food and Drug Administration (FDA), Dr. Scott Gottlieb, said the number of new cases of the COVID-19 has suggestively dropped in the last few weeks, and the trend will likely continue. Gottlieb added that the declining rate of coronavirus infection would continue as Americans receive the COVID-19 vaccine.

According to The Atlantic, CDC noted that new daily cases have staggered, and the rate of hospitalizations has toned down to almost 50 percent in the previous month. It added that some pandemic statistics are foggy, but the decline in the quality of COVID-19 infection is as clear as crystal. However, Healthline noted that the recent dip does not mean that the virus has been eradicated because cases can be back anytime, especially with the new variants.

Gottlieb noted that there are reasons to be optimistic. However, he seconded that the new COVID variants from the United Kingdom, Brazil, and South Africa can create more risks.